Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CPIX | US
0.01
0.81%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
04/10/2024
1.25
1.23
1.30
1.23
Cumberland Pharmaceuticals Inc. a specialty pharmaceutical company focuses on the acquisition development and commercialization of prescription products for hospital acute care gastroenterology and oncology in the United States and internationally. The company offers Acetadote an injection for the treatment of acetaminophen poisoning; Caldolor an injection for the treatment of pain and fever; Kristalose a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ an injection for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid juvenile idiopathic and severe psoriatic arthritis as well as disabling psoriasis. In addition the company is developing ifetroban a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease systemic sclerosis and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville Tennessee.
View LessStrength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
High Short-term Volatility
Microcap (<300M USD)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
38.3%1 month
41.9%3 months
37.1%6 months
53.3%-
-
0.66
0.82
0.27
106.32
0.57
-
-2.83M
17.62M
17.62M
-
-10.42
-
-9.60
-32.99
1.67
0.16
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.31
Range1M
0.31
Range3M
0.32
Rel. volume
1.78
Price X volume
33.96K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
MEI Pharma Inc | MEIP | Drug Manufacturers-Specialty & Generic | 2.81 | 18.72M | 2.18% | 1.09 | 0.00% |
BGXX | BGXX | Drug Manufacturers-Specialty & Generic | 0.0365 | 7.16M | 1.11% | n/a | 5.20% |
Biofrontera Inc. Common Stock | BFRI | Drug Manufacturers-Specialty & Generic | 0.96 | 5.32M | -10.28% | n/a | 13.20% |
Universe Pharmaceuticals INC | UPC | Drug Manufacturers-Specialty & Generic | 0.2179 | 5.15M | -5.30% | n/a | 13.87% |
Imc Mortgage Co | IMCC | Drug Manufacturers-Specialty & Generic | 2.27 | 5.07M | -1.30% | n/a | 222.75% |
Evoke Pharma Inc | EVOK | Drug Manufacturers-Specialty & Generic | 5.25 | 4.54M | 6.06% | n/a | 187.62% |
Guardion Health Sciences Inc | GHSI | Drug Manufacturers-Specialty & Generic | 3.3 | 4.24M | 1.54% | n/a | 0.00% |
Sonoma Pharmaceuticals Inc | SNOA | Drug Manufacturers-Specialty & Generic | 2.78 | 3.72M | -5.44% | n/a | 8.44% |
SHPH | SHPH | Drug Manufacturers-Specialty & Generic | 1.165 | 3.43M | -2.10% | n/a | 144.16% |
PETROS PHARMACEUTICALS INC | PTPI | Drug Manufacturers-Specialty & Generic | 0.355 | 3.41M | 2.90% | n/a | 83.11% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ILAG | ILAG | Building Products & Equipment | 1.0599 | 19.14M | -0.93% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.695 | 8.47M | -4.15% | n/a | 16.03% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.6199 | 5.90M | 6.82% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.33 | 5.20M | 0.03% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.3899 | 3.55M | -0.01% | n/a | 9.62% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4859 | 2.44M | -9.19% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 913.02K | -1.96% | n/a | -37.05% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.17 | 0 | 0.78% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 106.32 | 17.21 | Expensive |
Ent. to Revenue | 0.57 | 334.38 | Cheaper |
PE Ratio | - | 26.92 | - |
Price to Book | 0.66 | 12.15 | Cheaper |
Dividend Yield | - | 2.77 | - |
Std. Deviation (3M) | 37.11 | 68.34 | Lower Risk |
Debt to Equity | 0.82 | -1.00 | Expensive |
Debt to Assets | 0.27 | 0.48 | Cheaper |
Market Cap | 17.62M | 5.31B | Emerging |